Wednesday - September 2, 2026

Treatment of CD30-positive Cancer

2026-07-21

ALEXANDRIA, Virginia, July 21 -- THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, Chapel Hill, North Carolina has been assigned a patent (No. US 12685773 B2, initially filed June 4, 2021) developed by five inventors Aung Myo, Singapore, Singapore; Ivan David Horak, Singapore, Singapore; Jonathan Serody, Chapel Hill, North Carolina; Gianpietro Dotti, Chapel Hill, North Carolina; and Barbara Savoldo, Chapel Hill, North Carolina, for "Treatment of CD30-positive cancer." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Treatment of CD30-positive Cancer

Information Request Form

Copyright Targeted News Service 2026